Pharma responds to UK government Statutory Scheme rise
The ABPI and Lilly have responded to the UK government’s…
The ABPI and Lilly have responded to the UK government’s confirmed plans to increase the payment percentage in the Statutory Scheme to control the costs of branded medicines.